DR. EVAN D. ROSEN, MD, PH.D
Osteopathic Medicine at Brookline Ave, Boston, MA

License number
Massachusetts 154883
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address 2
330 Brookline Ave, Boston, MA 02215
25 Woodland St, Arlington, MA 02476
Phone
(617) 667-2151

Personal information

See more information about EVAN D. ROSEN at radaris.com
Name
Address
Phone
Evan Rosen
265 Willow Ave, Somerville, MA 02144
Evan Rosen, age 60
25 Woodland St, Arlington, MA 02476
(781) 316-1799
Evan J Rosen, age 50
45 Everett St, Medford, MA 02155
(781) 395-2211

Professional information

See more information about EVAN D. ROSEN at trustoria.com
Evan David Rosen Photo 1
Evan David Rosen, Boston MA

Evan David Rosen, Boston MA

Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism
Work:
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA 02215
Education:
University of Michigan Medical School (1994)


Evan D Rosen Photo 2
Dr. Evan D Rosen, Boston MA - MD (Doctor of Medicine)

Dr. Evan D Rosen, Boston MA - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism
Address:
Boston Office
330 Brookline Ave, Boston 02215
(617) 667-4811 (Phone), (617) 667-4833 (Fax)
Boston Office
330 Brookline Ave, Boston 02215
(617) 667-7000 (Phone), (617) 667-2927 (Fax)
Boston Office
330 Brookline Ave, Boston 02215
(617) 667-7000 (Phone), (617) 667-9696 (Fax)
Beth Israel Deaconess Med END
330 Brookline Ave SUITE 6GZ6, Boston 02215
(617) 667-1765 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2009, Internal Medicine, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Boston Office
330 Brookline Ave, Boston 02215
Boston Office
330 Brookline Ave, Boston 02215
Boston Office
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Med END
330 Brookline Ave SUITE 6GZ6, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Univ Of Mi Med Sch
Graduated: 1993
Brigham And Women'S Hospital
Mass General Hospital


Evan Rosen Photo 3
Use Of Lipocalin 2 In The Regulation Of Insulin Sensitivity

Use Of Lipocalin 2 In The Regulation Of Insulin Sensitivity

US Patent:
2010024, Sep 30, 2010
Filed:
Aug 29, 2007
Appl. No.:
12/438632
Inventors:
Evan D. Rosen - Arlington MA, US
International Classification:
A61K 31/07, C12Q 1/02, C12Q 1/68, G01N 33/53, A61K 39/395, C07C 43/02, C07K 16/00, A61P 3/10
US Classification:
4241721, 435 29, 435 6, 514725, 435 78, 568668, 5303898
Abstract:
Methods of identifying compounds that modulate lipocalin 2 activity or expression are described, as are methods of reducing insulin resistance or increasing insulin sensitivity by administering compounds that modulate lipocalin 2 expression. Methods of diagnosing insulin resistance or related conditions, by measuring lipocalin 2 activity, are also described.